Obesity, a major risk factor for immunity and severe outcomes of COVID-19.
Mohammad Tohidul AminKaniz FatemaSayema ArefinFahad HussainDipty Rani BhowmikMohammad Salim HossainPublished in: Bioscience reports (2021)
An influenza-like virus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for COVID-19 disease and spread worldwide within a short time. COVID-19 has now become a significant concern for public health. Obesity is highly prevalent worldwide and is considered a risk factor for impairing the adaptive immune system. Although diabetes, hypertension, cardiovascular disease (CVD), and renal failure are considered the risk factors for COVID-19, obesity is not yet well-considered. The present study approaches establishing a systemic association between the prevalence of obesity and its impact on immunity concerning the severe outcomes of COVID-19 utilizing existing knowledge. Overall study outcomes documented the worldwide prevalence of obesity, its effects on immunity, and a possible underlying mechanism covering obesity-related risk pathways for the severe outcomes of COVID-19. Overall understanding from the present study is that being an immune system impairing factor, the role of obesity in the severe outcomes of COVID-19 is worthy.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- insulin resistance
- metabolic syndrome
- type diabetes
- weight loss
- high fat diet induced
- weight gain
- cardiovascular disease
- public health
- glycemic control
- blood pressure
- risk factors
- healthcare
- drug induced
- coronary artery disease
- body mass index
- skeletal muscle
- cardiovascular risk factors